CENDAKIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Name

Type

Language

ABT-308

Preferred Name

English

CENDAKIMAB

Official Name

English

HUMANIZED ANTI-HUMAN IL-13 MONOCLONAL ANTIBODY

Common Name

English

IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER

Systematic Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL-13 (INTERLEUKIN 13, IL-13)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-453) (VH (HOMO SAPIENS IGHV2-5*08 (80.6%) -(IGHD) -IGHJ4*01 (100%)) (10.7.15) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G

Systematic Name

English

Cendakimab [WHO-DD]

Common Name

English

CENDAKIMAB [USAN]

Common Name

English

RPC-4046

Code

English

CC-93538

Code

English

cendakimab [INN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

443314

Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025

Code System Code Type Description

SMS_ID

300000005882

Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025

PRIMARY

INN

10990

Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025

PRIMARY

USAN

HI-139

Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025

PRIMARY

NCI_THESAURUS

C174792

Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025

PRIMARY

CAS

2151032-62-9

Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025

PRIMARY

FDA UNII

O8R9U9ZUVN

Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025

PRIMARY

ACTIVE MOIETY


					O8R9U9ZUVN